The 2′-valerate ester of 6-methoxypurine arabinoside (170U88), a nucleoside analog with anti-varicella zoster virus (VZV) activity, was given to monkeys and rats. In subchronic preclinical toxicity studies, dosing was by gavage to monkeys (distilled water vehicle) and rats (0.5% methylcellulose vehicle) for 90 days. Groups of 5 male and 5 female monkeys ( Macaca fascicularis) were given 170U88 at 0, 25, 50, or 100 mg/kg/day. The daily dose was given in two equal portions with 6 hr between doses. Monkeys in the high-dose group lost weight. Food consumption was decreased for mid- and high-dose monkeys and for low-dose female monkeys. Slightly decreased values for erythrocyte and leukocyte counts at the mid- and high dose were fully reversed during an 8-week recovery period. Two high-dose male monkeys and a middose female monkey developed signs of central nervous system toxicity and were necropsied before dosing was complete. These signs were first observed in the fifth week of dosing and included body tremors, incoordination, reduced activity, sleepiness, stupor, and lack of eye tracking. Axonal lesions were observed in histologic sections of sciatic nerve in monkeys at all dose levels. Neither the signs of central nervous system toxicity nor the axonal lesions reversed during the 8-week recovery period. Groups of 14 male and 14 female CD rats (Sprague-Dawley derived) were given single daily doses of 170U88 at 0, 150, 300, or 600 mg/kg. Body weights were decreased at all dose levels and food consumption was decreased for mid- and high-dose rats. Small increases in values for erythrocyte count, hemoglobin, and packed cell volume and small decreases in values for glucose, serum protein, and serum albumin were limited to high-dose rats and reversed during a 4-week recovery period. High-dose rats also had reversible liver lesions consisting of necrosis of individual hepatocytes, megalocytosis, occasional mitotic figures, and biliary stasis. Clinical and morphologic indications of central nervous system toxicity in the rats consisted of altered exploratory behavior at the high dose and groups of small vacuoles in cerebellar white matter at all dose levels. Cerebellar vacuolation was observed in rats examined at the end of the exposure period and also in rats examined after the 4-week postdose recovery period. Signs interpreted as peripheral nervous system toxicity were limited to rats in the high-dose group and consisted of hindquarter weakness, slow righting and placing reflexes, and ataxia. Again, these findings did not reverse during the recovery period. Thus, signs of both central and peripheral nervous system toxicity were observed in both monkeys and rats. These neurotoxic effects resulted in the decision to stop further development of 170U88.
Read full abstract